Henrik Bergentoft

Henrik Bergentoft serves as the Chief Financial Officer at Oncopeptides AB (publ) since October 2023, overseeing Finance, Legal, IT, and administration. Prior to this role, Bergentoft held CFO positions at RaySearch Laboratories from November 2022 to September 2023, C-RAD AB from March 2020 to November 2022, and MSAB from August 2016 to February 2020, where responsibilities included managing group finance functions across various countries and ensuring compliance with stock market reporting standards. Additional experience includes finance leadership roles at Aerocrine, Nordkom AB (publ), ContextVision AB, and Autoliv, along with auditing at Deloitte/Andersen. Henrik Bergentoft holds a Master’s degree in Business & Administration with a focus on Finance & Accounting from Uppsala University, earned in 1999.